OTCMKTS:CRLBF

Cresco Labs Competitors

$12.17
+0.33 (+2.79 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$11.52
Now: $12.17
$12.37
50-Day Range
$11.41
MA: $13.20
$15.50
52-Week Range
$3.00
Now: $12.17
$17.49
Volume736,192 shs
Average Volume1.42 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Cresco Labs (OTCMKTS:CRLBF) Vs. ABAHF, ACRGF, APPB, AYRSF, CANB, and CNTMF

Should you be buying CRLBF stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Cresco Labs, including Abacus Health Products (ABAHF), Acreage (ACRGF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), and Cansortium (CNTMF).

Abacus Health Products (OTCMKTS:ABAHF) and Cresco Labs (OTCMKTS:CRLBF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, analyst recommendations, risk, institutional ownership, profitability and earnings.

Profitability

This table compares Abacus Health Products and Cresco Labs' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abacus Health ProductsN/AN/AN/A
Cresco LabsN/AN/AN/A

Valuation and Earnings

This table compares Abacus Health Products and Cresco Labs' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abacus Health ProductsN/AN/AN/AN/AN/A
Cresco LabsN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings for Abacus Health Products and Cresco Labs, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abacus Health Products0000N/A
Cresco Labs01702.88

Cresco Labs has a consensus target price of $19.2125, indicating a potential upside of 57.90%. Given Cresco Labs' higher possible upside, analysts clearly believe Cresco Labs is more favorable than Abacus Health Products.

Summary

Cresco Labs beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.

Acreage (OTCMKTS:ACRGF) and Cresco Labs (OTCMKTS:CRLBF) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Profitability

This table compares Acreage and Cresco Labs' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AcreageN/AN/AN/A
Cresco LabsN/AN/AN/A

Valuation & Earnings

This table compares Acreage and Cresco Labs' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AcreageN/AN/AN/AN/AN/A
Cresco LabsN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and target prices for Acreage and Cresco Labs, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acreage01202.67
Cresco Labs01702.88

Acreage currently has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Cresco Labs has a consensus price target of $19.2125, indicating a potential upside of 57.90%. Given Acreage's higher possible upside, equities analysts clearly believe Acreage is more favorable than Cresco Labs.

Summary

Cresco Labs beats Acreage on 2 of the 3 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Cresco Labs (OTCMKTS:CRLBF) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Profitability

This table compares Applied Biosciences and Cresco Labs' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
Cresco LabsN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and target prices for Applied Biosciences and Cresco Labs, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
Cresco Labs01702.88

Cresco Labs has a consensus price target of $19.2125, indicating a potential upside of 57.90%. Given Cresco Labs' higher possible upside, analysts clearly believe Cresco Labs is more favorable than Applied Biosciences.

Valuation & Earnings

This table compares Applied Biosciences and Cresco Labs' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
Cresco LabsN/AN/AN/AN/AN/A

Summary

Cresco Labs beats Applied Biosciences on 2 of the 2 factors compared between the two stocks.

Cresco Labs (OTCMKTS:CRLBF) and Ayr Strategies (OTCMKTS:AYRSF) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Profitability

This table compares Cresco Labs and Ayr Strategies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cresco LabsN/AN/AN/A
Ayr StrategiesN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings and price targets for Cresco Labs and Ayr Strategies, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cresco Labs01702.88
Ayr Strategies01602.86

Cresco Labs currently has a consensus price target of $19.2125, indicating a potential upside of 57.90%. Ayr Strategies has a consensus price target of $34.8571, indicating a potential upside of 63.96%. Given Ayr Strategies' higher possible upside, analysts plainly believe Ayr Strategies is more favorable than Cresco Labs.

Valuation and Earnings

This table compares Cresco Labs and Ayr Strategies' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cresco LabsN/AN/AN/AN/AN/A
Ayr StrategiesN/AN/AN/AN/AN/A

Summary

Cresco Labs beats Ayr Strategies on 2 of the 3 factors compared between the two stocks.

Cresco Labs (OTCMKTS:CRLBF) and Can B (NASDAQ:CANB) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Profitability

This table compares Cresco Labs and Can B's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cresco LabsN/AN/AN/A
Can BN/AN/AN/A

Valuation and Earnings

This table compares Cresco Labs and Can B's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cresco LabsN/AN/AN/AN/AN/A
Can BN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings and price targets for Cresco Labs and Can B, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cresco Labs01702.88
Can B0000N/A

Cresco Labs currently has a consensus price target of $19.2125, indicating a potential upside of 57.90%. Given Cresco Labs' higher possible upside, equities research analysts plainly believe Cresco Labs is more favorable than Can B.

Summary

Cresco Labs beats Can B on 2 of the 2 factors compared between the two stocks.

Cresco Labs (OTCMKTS:CRLBF) and Cansortium (OTCMKTS:CNTMF) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares Cresco Labs and Cansortium's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cresco LabsN/AN/AN/A
CansortiumN/AN/AN/A

Earnings & Valuation

This table compares Cresco Labs and Cansortium's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cresco LabsN/AN/AN/AN/AN/A
CansortiumN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Cresco Labs and Cansortium, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cresco Labs01702.88
Cansortium00103.00

Cresco Labs presently has a consensus target price of $19.2125, indicating a potential upside of 57.90%. Cansortium has a consensus target price of $1.20, indicating a potential upside of 18.81%. Given Cresco Labs' higher possible upside, analysts plainly believe Cresco Labs is more favorable than Cansortium.

Summary

Cresco Labs beats Cansortium on 2 of the 3 factors compared between the two stocks.


Cresco Labs Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ABAHF
Abacus Health Products
0.4$4.84+5.4%$0.00N/A0.00Gap Up
Acreage logo
ACRGF
Acreage
1.2$2.77+0.0%$0.00N/A0.00
Applied Biosciences logo
APPB
Applied Biosciences
0.5$0.22+77.3%$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Up
AYRSF
Ayr Strategies
1.4$21.26+0.0%$0.00N/A0.00
Can B logo
CANB
Can B
0.4$0.53+7.6%$0.00N/A0.00Gap Up
Cansortium logo
CNTMF
Cansortium
0.9$1.01+3.0%$0.00N/A0.00
Charlotte's Web logo
CWBHF
Charlotte's Web
1.3$4.06+1.0%$0.00N/A0.00
Choom logo
CHOOF
Choom
0.5$0.09+0.0%$0.00N/A0.00Gap Down
CPHRF
Cipher Pharmaceuticals
1.2$1.08+0.9%$0.00N/A0.00Decrease in Short Interest
CLS Holdings USA logo
CLSH
CLS Holdings USA
0.7$0.22+4.5%$0.00N/A0.00News Coverage
Gap Down
Cosmos logo
COSM
Cosmos
0.5$5.40+1.9%$0.00N/A0.00High Trading Volume
Increase in Short Interest
Gap Down
Curaleaf logo
CURLF
Curaleaf
1.6$13.84+1.2%$0.00N/A0.00
HMDEF
DionyMed Brands
0.5N/AN/A$0.00N/A0.00High Trading Volume
Easton Pharmaceuticals logo
EAPH
Easton Pharmaceuticals
0.5$0.00+0.0%$0.00N/A0.00Decrease in Short Interest
Gap Up
Elixinol Global logo
ELLXF
Elixinol Global
0.8$0.14+0.0%$0.00N/A0.00Gap Down
EVIO logo
EVIO
EVIO
0.6$0.00+0.0%$0.00N/A0.00News Coverage
Gap Down
Flower One logo
FLOOF
Flower One
0.4$0.22+9.1%$0.00N/A0.00
Golden Leaf logo
GLDFF
Golden Leaf
0.5$0.05+0.0%$0.00N/A0.00News Coverage
Green Growth Brands logo
GGBXF
Green Growth Brands
0.4$0.01+0.0%$0.00N/A0.00Gap Up
Green Thumb Industries logo
GTBIF
Green Thumb Industries
1.7$28.20+3.9%$0.00N/A0.00Gap Down
GTEC logo
GGTTF
GTEC
0.6$0.62+3.2%$0.00N/A0.00Increase in Short Interest
Gap Up
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.88+2.1%$0.00N/A0.00Gap Down
Hemp Naturals logo
HPMM
Hemp Naturals
0.6$0.01+0.0%$0.00N/A0.00
Hexo logo
HYYDF
Hexo
0.6N/AN/A$0.00N/A0.00News Coverage
Hikma Pharmaceuticals logo
HKMPY
Hikma Pharmaceuticals
0.4$59.68+0.0%$0.00N/A0.00
iAnthus Capital logo
ITHUF
iAnthus Capital
0.6$0.22+0.0%$0.00N/A0.00Gap Down
Icanic Brands logo
ICNAF
Icanic Brands
0.6$0.31+3.3%$0.00N/A0.00Decrease in Short Interest
News Coverage
KNHBF
ICC International Cannabis
0.6N/AN/A$0.00N/A0.00
Invictus MD Strategies logo
IVITF
Invictus MD Strategies
0.6$0.04+0.0%$0.00N/A0.00Decrease in Short Interest
Gap Up
Isodiol International logo
ISOLF
Isodiol International
0.4$0.07+0.0%$0.00N/A0.00Gap Up
Khiron Life Sciences logo
KHRNF
Khiron Life Sciences
1.4$0.40+2.5%$0.00N/A0.00Decrease in Short Interest
Gap Down
KHTRF
Knight Therapeutics
1.2$4.20+0.5%$0.00N/A0.00High Trading Volume
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01+0.0%$0.00N/A0.00Increase in Short Interest
News Coverage
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.04+0.0%$0.00N/A0.00Gap Down
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.38+0.0%$0.00N/A0.00Analyst Report
Increase in Short Interest
News Coverage
MedMen Enterprises logo
MMNFF
MedMen Enterprises
0.8$0.29+3.4%$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$35.76+1.1%$0.00N/A0.00Increase in Short Interest
News Coverage
MJardin Group logo
MJARF
MJardin Group
1.1$0.07+0.0%$0.00N/A0.00Gap Down
MYHI
Mountain High Acquisitions
0.5$0.02+0.0%$0.00N/A0.00Gap Up
PHCEF
Pharmacielo
0.7$1.25+7.2%$0.00N/A0.00Gap Down
Plus Products logo
PLPRF
Plus Products
1.1$0.52+7.7%$0.00N/A0.00Decrease in Short Interest
Gap Down
Premier Biomedical logo
BIEI
Premier Biomedical
0.5$0.00+0.0%$0.00N/A0.00Gap Down
PCYN
Procyon
0.4$0.60+0.0%$0.00N/A0.00
Pure Global Cannabis logo
PRCNF
Pure Global Cannabis
0.7$0.01+0.0%$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
SANP
Santo Mining
0.5$0.01+0.0%$0.00N/A0.00News Coverage
Gap Up
Shionogi & Co., Ltd. logo
SGIOY
Shionogi & Co., Ltd.
0.5$13.25+1.1%$0.00N/A0.00Increase in Short Interest
DNPUF
Sumitomo Dainippon Pharma
0.5$17.40+0.0%$0.00N/A0.00News Coverage
TerrAscend logo
TRSSF
TerrAscend
1.7$10.02+0.0%$0.00N/A0.00Analyst Report
Increase in Short Interest
Gap Down
The Flowr logo
FLWPF
The Flowr
1.5$0.25+0.0%$0.00N/A0.00Gap Down
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.0$0.30+3.3%$0.00N/A0.00Analyst Report
News Coverage
Gap Up
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.